← FDA DRUG APPROVALS

FDA ANDA · ANDA065196

CEFTAZIDIME

Sponsor: WOCKHARDT

APPLICATION
ANDA065196
TYPE
ANDA
ORIGINAL APPROVAL
2008-10-15
LATEST ACTION
2008-10-15
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CEFTAZIDIMEDiscontinued
CEFTAZIDIME 1GM/VIAL · INJECTABLE · INJECTION

Approval history

2008-10-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →